MilliporeSigma Announces Conferring of 2021 Young Scientists Awards
News Release
Burlington, MA, December 11, 2021 – MilliporeSigma, the Life Science business sector of Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that the Life Science business in Indonesia conferred its 2021 Indonesia Young Scientist Award to five winners. This year, the Life Science business in Indonesia received 120 research applications in three categories: biological sciences, chemical sciences, and COVID-19 studies.
“We are committed to supporting and encouraging young researchers to conduct research and discover new inventions in life science that will impact life and health. The strong research submissions are a testament to the interest of pioneering life science research in Indonesia, one of the fastest-growing countries in Asia,” said Christopher Thomas, President Director of PT Merck Chemicals and Life Science, Jakarta, Indonesia, an affiliate of Merck KGaA, Darmstadt, Germany.
The winners were:
- Athanasia Amanda Septevani, S.T., Ph.D., for her research titled “Advancement of Green Biorefinery: Lignin Derived from Biomass Black Liquor Sludge towards Eco-Friendly and High-Performance of Flame Retardant.”
- apt. Pietradewi Hartrianti, S.Farm, M.Farm. for her research titled “Self-Healing Properties of Keratin Composite Hydrogels and Their Prospect as Bio-ink for 3D-Printed Organoid Model.”
- Andri Hardiansyah, S.T., M.T., Ph.D., for his research titled “Facile and Green Synthesis of Hydrogels of Graphene/Polymer for Tissue Engineering and Drug Delivery Applications: Evaluation of Chemical Interaction, Structure, Cellular In Vitro Study and Response to The External Stimuli.”
- apt. Febri Wulandari, S.Farm, for her research titled “Estimating The Anti-Proliferative Effects of A New Monocarbonyl Curcumin Analog with Fluor Substituent, FCCA-1, in Combination with Doxorubicin.”
- apt. Yesiska Kristina Hartanti, S.Farm, for her research titled “Lumbricus rubellus Protein Fraction DLBS1033N Prevents High Glucose-Induced Schwann Cell Cytotoxicity: The Role of Cell Viability, Apoptosis, and Differentiation in An In Vitro Model for Diabetic Neuropathy.”
The Young Scientist Award was introduced in 2018 to recognize Indonesia-based research, particularly the projects that help people achieve a better quality of life while increasing awareness of life science research and discoveries as the solution to life challenges in Indonesia. The award is open to university students and aspiring or professional scientists from state-owned or private research institutions and hospitals.
“We selected the finalists based on three qualifications: research process and execution; creativity and authenticity of ideas (originality), as well as research potentiality of embracing community’s wellness and the life science businesses. We are pleased to see enthusiastic young researchers who have submitted their research and given their contribution to general and life science development,” said Dr. Ratih Asmana Ningrum Head of the National Research and Innovation Agency’s (BRIN) Biotechnology Research Center, also Chair of the Young Scientist Award judging panel.
The Life Science business sector is committed to supporting young researchers in Indonesia to keep innovating for the future. In March 2021, a partnership was established with Universitas Indonesia’s Mathematics and Natural Sciences Faculty to provide a collaborative lab that provides access to leading-edge equipment, services, and expertise to produce scientific research and innovation.
The Life Science business sector of Merck KGaA, Darmstadt, Germany focuses on three segments: research solutions for academia; process solutions for biopharmaceutical production; and applied solutions for clinical and diagnostic testing laboratories as well as the food-and-beverage and environmental industries.
About the Life Science business of Merck KGaA, Darmstadt, Germany
The Life Science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada, has more than 23,000 employees and 59 manufacturing sites worldwide, with a portfolio of more than 300,000 products focused on scientific discovery, biomanufacturing and testing services. Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and electronics.
Around 58,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene-editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2020, Merck KGaA, Darmstadt, Germany generated sales of € 17.5 billion in 66 countries.
The company holds the global rights to the name and trademark “Merck” internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Electronics. Since its founding 1668, scientific exploration and responsible entrepreneurship have been key to the company’s technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company. For more information about Merck KGaA, Darmstadt, Germany, visit www.emdgroup.com.
All Merck KGaA, Darmstadt, Germany news releases are distributed by email at the same time they become available on the EMD Group website. In case you are a resident of the U.S. or Canada please go to www.emdgroup.com/subscribe to register again for your online subscription of this service as our newly introduced geo-targeting requires new links in the email. You may later change your selection or discontinue this service.
Follow MilliporeSigma on Twitter @MilliporeSigma, on Facebook @MilliporeSigma and on LinkedIn.
To continue reading please sign in or create an account.
Don't Have An Account?